Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 2
2(66.7%)
Early Phase 1
1(33.3%)
3Total
Phase 2(2)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01147653Phase 2Completed

A Randomized Study of Autologous Umbilical Cord Blood Reinfusion in Children With Cerebral Palsy

Role: collaborator

NCT02612155Phase 2Completed

A Multi-site Study of Autologous Cord Blood Cells for Hypoxic Ischemic Encephalopathy

Role: collaborator

NCT00532753Early Phase 1Unknown

Evaluating the Hunger Project in Ghana

Role: collaborator

All 3 trials loaded